Analyst Says DeepSeek Breakthrough Could Negatively Impact Oracle Corporation (ORCL)
We recently published a list of 10 AI Stocks on Wall Street’s Radar After DeepSeek Breakthrough. In this article, we are ...
Gov. Evers, OCI Announce a Record-Breaking 313,579 Wisconsinites Enroll in Health Coverage ...
We are glad to be able to provide a resource like WisCovered.com to share accurate, unbiased information about health ...
Altria Group Inc (MO) Q4 2024 Earnings Call Highlights: Strong Financial Performance Amid ...
Altria Group Inc (MO) reports robust earnings growth and shareholder returns, while navigating the complexities of the ...
GitHub14 天
Oracle Cloud Infrastructure Ansible Collection
We recommend you to refer to the Migration Guide for breaking changes. Also, the new modules are renamed to use the service name as a prefix. We support almost all the of OCI Cloud services with very ...
Hindustan Times18 天
SS Rajamouli writes ‘7 Padma Awards for Telugu people this time’ in new post, internet ...
23 of the awardees are women and the list also includes 10 persons from the category of Foreigners/NRI/PIO/OCI and 13 posthumous awardees.
NBC News21 天
Federal regulations paused, halting FDA's proposed ban on formaldehyde in hair products
The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...
Newsweek22 天
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
CNN22 天
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
Popular Science22 天
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
UPI22 天
FDA approves Spravato, first monotherapy nasal spray to treat depression
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
Reuters23 天
FDA approves standalone use of J&J's ketamine-derived depression treatment
Jan 21 (Reuters) - The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's (JNJ.N), opens new tab nasal spray, Spravato, to allow it to be used as a standalone treatment ...
UVA Today23 天
FDA Bans Red Dye No. 3 in Food, Decades After Banning It in Cosmetics
The U.S. Food and Drug Administration has banned the use of red dye No. 3 in foods, more than three decades after researchers discovered its link to cancer in rodents and to worsened attention deficit ...